U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 12b-25

                        Commission File Number 000-24921

                           NOTIFICATION OF LATE FILING

(Check One):  [ ] Form 10-K/KSB  [ ] Form 20-F  [ ] Form 11-K  [X] Form 10-Q/QSB
              [ ] Form N-SAR

      For the Period Ended: June 30, 2002

      [ ]  Transition Report on Form 10-K
      [ ]  Transition Report on Form 20-F
      [ ]  Transition Report on Form 11-K
      [ ]  Transition Report on Form 10-Q
      [ ]  Transition Report on Form N-SAR

      For the Transition Period Ended: ________________

      Read attached  instruction  sheet before  preparing form.  Please print or
type.

      Nothing in this form shall be construed to imply that the  Commission  has
verified any information contained herein.

      If the  notification  relates to a portion of the  filing  checked  above,
identify the item(s) to which the notification relates:

                                     PART I
                             REGISTRANT INFORMATION

                         SURGICAL SAFETY PRODUCTS, INC.
                             Full Name of Registrant

                          One Sarasota Tower, Suite 608
                             2 North Tamiami Trail
            Address of Principal Executive Office (Street and Number)

                               Sarasota, FL 34236
                            City, State and Zip Code


                                       1


                                     PART II
                             RULE 12b-25(b) AND (c)

        If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate.)

                (a) The reasons described in reasonable detail in Part III of this
                    form could not be eliminated without unreasonable effort or
                    expense;

        [X]     (b) The subject annual report, semi-annual report, transition
                    report on Form 10-K, Form 20-F, Form 11-K or Form N-SAR, or
                    portion thereof will be filed on or before the 15th calendar
                    day following the prescribed due date; or the subject
                    quarterly report or transition report on Form 10-Q, or portion
                    thereof will be filed on or before the fifth calendar day
                    following the prescribed due date; and

                (c) The accountant's statement or other exhibit required by Rule
                    12b-25(c) has been attached if applicable.


                                    PART III
                                    NARRATIVE

State below in reasonable detail why the Form 10-K, 11-K, 20-F 10-Q, N-SAR or
the transition report portion thereof could not be filed within the prescribed
time period.

(Attach extra sheets if needed.)

        N/A

                                     PART IV

                                OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification

                            Timothy Novak, President
                                 (941) 953-9848
                      (Name) (Area Code) (Telephone Number)

                                       2


(2) Have all other periodic reports required under Section 13 or 15(d) of the
    Securities Exchange Act of 1934 or Section 30 of the Investment Company
    Act of 1940 during the preceding 12 months or for such shorter period
    that the registrant was required to file such report(s) been filed? If
    the answer is no, identify report(s).      [X] Yes [ ] No

(3) Is it anticipated that any significant change in results of operations from
    the corresponding period for the last fiscal year will be reflected by the
    earnings statements to be included in the subject report or portion
    thereof?                                   [ ] Yes [X] No

        If so: attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.

     Surgical Safety Products, Inc. has caused this notification to be signed on its behalf by
the undersigned officer, thereunto duly authorized.

Date: August 14, 2002               Surgical Safety Products, Inc.

                                    By: /s/ Timothy Novak

                                    Title:  President

                                       3